1
|
Stamate Cretan M, Ochiuz L, Ghizdovat V, Molcalut M, Agop M, Gafițanu CA, Barsan (Bujor) A, Sha’at M, Stamate C. Formulation and In Vitro Evaluation of Matrix Tablets Containing Ketoprofen-Beta Cyclodextrin Complex for Enhanced Rheumatoid Arthritis Therapy: Experimental and Computational Insights. Pharmaceutics 2025; 17:474. [PMID: 40284469 PMCID: PMC12030514 DOI: 10.3390/pharmaceutics17040474] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2025] [Revised: 04/01/2025] [Accepted: 04/02/2025] [Indexed: 04/29/2025] Open
Abstract
Background: Rheumatoid arthritis is a chronic autoimmune disease that leads to severe disability and requires improved therapeutic strategies to optimize anti-inflammatory treatment. This study aimed to address this challenge by developing and characterizing an extended-release polymer matrix tablet containing ketoprofen and a ketoprofen-β-cyclodextrin complex with enhanced therapeutic properties. The objective was to improve inflammation management and therapeutic outcomes using a novel delivery system based on the inclusion of the active substance in cyclodextrin complexes. Methods: Tablets were formulated using ketoprofen and ketoprofen-β-cyclodextrin complexes combined with hydrophilic polymers such as Carbopol® 971P NF, Kollidon® VA 64, and MethocelTM K4M. The complexes were obtained via the coprecipitation method to improve bioavailability. The kinetics of the release of ketoprofen, ketoprofen-β-cyclodextrin complex (2:1), and ketoprofen-β-cyclodextrin complex (1:1) from the tablets were investigated in vitro in artificial gastric and intestinal fluids, and drug release profiles were established. Advanced mathematical models were used to describe the nonlinear behavior of the drug-polymer systems. Results: The inclusion of ketoprofen in the β-cyclodextrin complexes was confirmed, revealing distinct release profiles. Tablets (K-3 F-3) containing the 1:1 complex showed rapid release (96.2% in 4-7 h), while tablets (K-1 F-4) containing free ketoprofen released 76% over 9-11 h. Higher polymer concentrations slowed the release due to gel barrier formation. Pharmacotechnical and stability tests supported their suitability as extended-release forms. A multifractal modeling approach described the release dynamics, treating the polymer-drug matrix as a complex system, with release curves characterized by variations in the fractal dimension and resolution. Conclusions: Specific hydrophilic polymer combinations effectively prolonged ketoprofen release. The developed matrix tablets, which were evaluated via in vitro studies and mathematical modeling, show promise for improving therapeutic outcomes and patient compliance during rheumatoid arthritis treatment.
Collapse
Affiliation(s)
- Monica Stamate Cretan
- Department of Pharmaceutical Technology, Faculty of Pharmacy, “Grigore T. Popa” University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania; (M.S.C.); (C.A.G.); (A.B.); (M.S.)
| | - Lacramioara Ochiuz
- Department of Pharmaceutical Technology, Faculty of Pharmacy, “Grigore T. Popa” University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania; (M.S.C.); (C.A.G.); (A.B.); (M.S.)
| | - Vlad Ghizdovat
- Biophysics and Medical Physics Department, “Grigore T. Popa” University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania;
| | - Monica Molcalut
- Faculty of Physics, “Alexandru Ioan Cuza” University, Blvd. Carol I, No. 11, Iasi 700506, Romania;
| | - Maricel Agop
- Department of Physics, “Gheorghe Asachi” Technical University of Iasi, Prof. Dr. Docent Dimitrie Mangeron Rd., No. 59A, 700050 Iasi, Romania;
- Romanian Scientists Academy, 54 Splaiul Independentei, 050094 Bucharest, Romania
| | - Carmen Anatolia Gafițanu
- Department of Pharmaceutical Technology, Faculty of Pharmacy, “Grigore T. Popa” University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania; (M.S.C.); (C.A.G.); (A.B.); (M.S.)
| | - Alexandra Barsan (Bujor)
- Department of Pharmaceutical Technology, Faculty of Pharmacy, “Grigore T. Popa” University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania; (M.S.C.); (C.A.G.); (A.B.); (M.S.)
| | - Mousa Sha’at
- Department of Pharmaceutical Technology, Faculty of Pharmacy, “Grigore T. Popa” University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania; (M.S.C.); (C.A.G.); (A.B.); (M.S.)
| | - Ciprian Stamate
- Department of Mechanical Engineering, Mechatronics and Robotics, “Gheorghe Asachi” Technical University of Iasi, Prof. Dr. Docent Dimitrie Mangeron Rd., No. 43, 700050 Iasi, Romania;
| |
Collapse
|
2
|
Pullano SA, Marcianò G, Bianco MG, Oliva G, Rania V, Vocca C, Cione E, De Sarro G, Gallelli L, Romeo P, La Gatta A, Fiorillo AS. FT-IR Analysis of Structural Changes in Ketoprofen Lysine Salt and KiOil Caused by a Pulsed Magnetic Field. Bioengineering (Basel) 2022; 9:bioengineering9100503. [PMID: 36290471 PMCID: PMC9598906 DOI: 10.3390/bioengineering9100503] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2022] [Revised: 09/05/2022] [Accepted: 09/06/2022] [Indexed: 11/16/2022] Open
Abstract
High-intensity, low-frequency magnetic fields (MFs) have been widely used in the treatment of diseases and in drug delivery, even though they could induce structural changes in pharmacological molecules. Morphological changes in ketoprofen and KiOil were investigated through Fourier-transform infrared spectroscopy (FT-IR). Unsupervised principal component analysis was carried out for data clustering. Clinical validation on 22 patients with lower back pain was managed using diamagnetic therapy plus topical ketoprofen or KiOil. The Numerical Rating Scale (NRS) and Short-Form Health Survey 36 (SF-36) were used to evaluate clinical and functional response. Ketoprofen showed clear clustering among samples exposed to MF (4000−650 cm−1), and in the narrow frequency band (1675−1475 cm−1), results evidenced structural changes which involved other excipients than ketoprofen. KiOil has evidenced structural modifications in the subcomponents of the formulation. Clinical treatment with ketoprofen showed an average NRS of 7.77 ± 2.25 before and an average NRS of 2.45 ± 2.38 after MF treatment. There was a statistically significant reduction in NRS (p = 0.003) and in SF-36 (p < 0.005). Patients treated with KiOil showed an average NRS of 7.59 ± 2.49 before treatment and an average NRS of 1.90 ± 2.26 after treatment (p < 0.005). SF-36 showed statistical significance for all items except limitations due to emotional problems. A high-intensity pulsed magnetic field is an adjunct to topical treatment in patients with localized pain, and the effect of MF does not evidence significant effects on the molecules.
Collapse
Affiliation(s)
- Salvatore Andrea Pullano
- BATS Laboratory, Department of Health Sciences, “Magna Græcia” University of Catanzaro, 88100 Catanzaro, Italy
| | - Gianmarco Marcianò
- Clinical Pharmacology and Pharmacovigilance Unit, Department of Health Sciences, “Magna Græcia” University of Catanzaro, Mater Domini Hospital, 88100 Catanzaro, Italy
| | - Maria Giovanna Bianco
- Department of Surgical and Medical Sciences, “Magna Græcia” University of Catanzaro, 88100 Catanzaro, Italy
| | - Giuseppe Oliva
- BATS Laboratory, Department of Health Sciences, “Magna Græcia” University of Catanzaro, 88100 Catanzaro, Italy
| | - Vincenzo Rania
- Clinical Pharmacology and Pharmacovigilance Unit, Department of Health Sciences, “Magna Græcia” University of Catanzaro, Mater Domini Hospital, 88100 Catanzaro, Italy
| | - Cristina Vocca
- Clinical Pharmacology and Pharmacovigilance Unit, Department of Health Sciences, “Magna Græcia” University of Catanzaro, Mater Domini Hospital, 88100 Catanzaro, Italy
| | - Erika Cione
- Department of Pharmacy, Health and Nutritional Sciences, Department of Excellence 2018–2022, University of Calabria, Ed. Polifunzionale, Arcavacata di Rende, 87036 Rende, Italy
- GalaScreen Laboratories, University of Calabria, Ed. Polifunzionale, Arcavacata di Rende, 87036 Rende, Italy
- Medifarmagen SRL, University of Catanzaro, 88100 Catanzaro, Italy
| | - Giovambattista De Sarro
- Clinical Pharmacology and Pharmacovigilance Unit, Department of Health Sciences, “Magna Græcia” University of Catanzaro, Mater Domini Hospital, 88100 Catanzaro, Italy
- FAS@UMG Research Center, Department of Health Sciences, “Magna Græcia” University of Catanzaro, 88100 Catanzaro, Italy
| | - Luca Gallelli
- Clinical Pharmacology and Pharmacovigilance Unit, Department of Health Sciences, “Magna Græcia” University of Catanzaro, Mater Domini Hospital, 88100 Catanzaro, Italy
- Department of Pharmacy, Health and Nutritional Sciences, Department of Excellence 2018–2022, University of Calabria, Ed. Polifunzionale, Arcavacata di Rende, 87036 Rende, Italy
- GalaScreen Laboratories, University of Calabria, Ed. Polifunzionale, Arcavacata di Rende, 87036 Rende, Italy
- Medifarmagen SRL, University of Catanzaro, 88100 Catanzaro, Italy
- FAS@UMG Research Center, Department of Health Sciences, “Magna Græcia” University of Catanzaro, 88100 Catanzaro, Italy
| | - Pietro Romeo
- Department of Orthopedics, Istituto di Ricovero E Cura A Carattere Scientifico, Istituto Ortopedico Galeazzi, 20123 Milan, Italy
| | - Antonio La Gatta
- BATS Laboratory, Department of Health Sciences, “Magna Græcia” University of Catanzaro, 88100 Catanzaro, Italy
| | - Antonino S. Fiorillo
- BATS Laboratory, Department of Health Sciences, “Magna Græcia” University of Catanzaro, 88100 Catanzaro, Italy
- Correspondence:
| |
Collapse
|